Last reviewed · How we verify

NCT03570853

Stress Management and Resiliency Training for Physicians

Status unknown NA Last updated 24 February 2021
What this trial tests

NA trial testing SMART-3RP in Burnout, Professional in 160 participants. Status unknown.

Timeline
9 July 2018
Primary endpoint
30 June 2021
30 June 2021

Quick facts

Lead sponsorMassachusetts General Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment160
Start date9 July 2018
Primary completion30 June 2021
Estimated completion30 June 2021
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Massachusetts General Hospital

Who can join

18 and older, any sex, with Burnout, Professional or Stress. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is to evaluate the effects of the SMART-3RP (Stress Management and Resiliency Training Relaxation Response Resiliency Program) on physician and academic faculty well-being, perceived stress, burnout, compassion, and job satisfaction.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of SMART-3RP

Trials testing the same drug.

Other recruiting trials for Burnout, Professional

Currently open trials in the same condition.

Other Massachusetts General Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03570853.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing